CommercialAdministrativeLow impact
06.02.09g, Human Immunodeficiency Virus (HIV) Genotyping and Phenotyping (Independence Administrators)
Independence Blue Cross·Infectious Disease, Internal Medicine, Family Medicine +1 more·Medical Policy
Effective date
Mar 4, 2026
We identified it
Jun 19, 2026
Summary
This is a routine annual policy reissue with no substantive changes to HIV genotyping and phenotyping coverage criteria. The only modification is a disclaimer language update effective 03/04/2026 that excludes members whose groups have enrolled in the UM vendor program from this policy's applicability.
Action Required
By March 4, 2026: Billing team must update member eligibility verification procedures to confirm whether each member's group has enrolled in the UM vendor program. If a group has enrolled in the UM vendor program, this policy (06.02.09g) no longer applies—refer members to the eviCore Lab Management Program policy instead. Update billing system notes and front-desk verification scripts to reflect this distinction. Failure to apply the correct policy may result in inappropriate claim denials or approvals.